Recently, it has been demonstrated that the miRNA-320 family suppresses stem cell-like characteristics in prostate cancer cells by down-regulating the Wnt/beta-catenin signaling pathway [49]—a pathway which is also of central importance for regulation of self-renewal and proliferation in hematopoietic stem cells [50,51]. The gene discussed is CTNNB1; the disease is prostate carcinoma.